Physical Activity Inversely Tied to COPD Symptom Burden
By Lori Solomon HealthDay Reporter
WEDNESDAY, Nov. 15, 2023 -- Moderate- to vigorous-intensity physical activity (MVPA) is inversely associated with symptom burden in individuals with chronic obstructive pulmonary disease (COPD), according to a study recently published online in Chronic Obstructive Pulmonary Diseases.
Loes Oostrik, from Utrecht University in the Netherlands, and colleagues evaluated the relationship between symptom burden and MVPA in individuals from a population-based sample mirroring the general population. The analysis included 406 participants with mild COPD, 287 participants with moderate COPD, 347 healthy individuals, and 474 individuals at risk for developing COPD.
The researchers found significant associations between high symptom burden and lower MVPA levels in the overall COPD sample (β = −717.09) and in the moderate COPD subgroup (β = −694.1). COPD was previously undiagnosed in 72 percent of the participants with COPD. Compared with individuals with physician-diagnosed COPD, the undiagnosed participants had significantly higher MVPA (β = −592.41).
"It can be difficult and scary to exercise while experiencing symptoms like breathlessness," Stephanie Williams, R.R.T., the COPD Foundation vice president of education and engagement, said in a statement. "However, regular exercise like gentle yoga and walking -- under the supervision of a doctor -- can improve COPD symptoms and quality of life for those living with the disease."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
Researchers Compare Race-Based, Race-Neutral Lung Function Equations
TUESDAY, May 21, 2024 -- The use of race-based and race-neutral equations for lung-function testing generate similarly accurate predictions of respiratory outcomes, but differ in...
Pulmonologist Intervention Beneficial for Undiagnosed Asthma, COPD
TUESDAY, May 21, 2024 -- For adults with undiagnosed asthma and chronic obstructive pulmonary disease (COPD), receipt of pulmonologist-directed treatment is associated with less...
Dupilumab Tied to Fewer Exacerbations in COPD With Type 2 Inflammation
TUESDAY, May 21, 2024 -- Dupilumab is associated with fewer exacerbations for patients with chronic obstructive pulmonary disease (COPD) with type 2 inflammation, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.